Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease
- Authors: Rudenko TE1, Kamyshova ES1, Vasilyeva MP1, Bobkova IN1, Solomakhina NI1, Shvetsov MY.1,2
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- M.V. Lomonosov Moscow State University, Faculty of Fundamental Medicine
- Issue: Vol 90, No 9 (2018)
- Pages: 60-67
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32991
- DOI: https://doi.org/10.26442/terarkh201890960-67
- ID: 32991
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
T E Rudenko
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: atatianaer@yandex.ru
к.м.н., ассистент каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического факультета Moscow, Russia
E S Kamyshova
I.M. Sechenov First Moscow State Medical University (Sechenov University)к.м.н., ассистент каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического факультета Moscow, Russia
M P Vasilyeva
I.M. Sechenov First Moscow State Medical University (Sechenov University)к.м.н., врач-нефролог отд-ния «Искусственная почка» клиники нефрологии, внутренних и профессиональных болезней им. Е.М. Тареева Университетской клинической больницы №3 Moscow, Russia
I N Bobkova
I.M. Sechenov First Moscow State Medical University (Sechenov University)д.м.н., проф., каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического факультета Moscow, Russia
N I Solomakhina
I.M. Sechenov First Moscow State Medical University (Sechenov University)д.м.н., проф., каф. госпитальной терапии №1 лечебного факультета Moscow, Russia
M Yu Shvetsov
I.M. Sechenov First Moscow State Medical University (Sechenov University); M.V. Lomonosov Moscow State University, Faculty of Fundamental Medicineк.м.н., доцент, каф. внутренних, профессиональных болезней и пульмонологии медико-профилактического факультета Первого МГМУ им. И.М. Сеченова (Сеченовский университет); доцент каф. внутренних болезней факультета фундаментальной медицины МГУ им. М.В. Ломоносова Moscow, Russia
References
- Мухин Н.А., Моисеев В.С. Кардиоренальные соотношения и риск сердечно - сосудистых заболеваний. Вестник РАМН. 2003;11:50-5
- Ronco C, Chionh C.Y, Haapio M, Anavekar N.S, House A, Bellomo R. The cardiorenal syndrome. Blood Purif. 2009;27(1):114-26. https://doi.org/ 10.1159/000167018
- Schiffrin E.L, Lipman M, Mann J.F.E. Chronic kidney disease. Effects on the cardiorenal system. Circulation. 2007;116(1):85-97. https://doi.org/10.1161/ CIRCULATIONAHA.106.678342
- Longhini C, Molino C, Fabbian F. Cardiorenal syndrome: still not a defined entity. Clinical and Experimental Nephrology. 2010;14(1):12-21.https://doi.org/10.1007/s10157-009-0257-4
- Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Арутюнов Г.П., Беграмбекова Ю.Л., Беленков Ю.Н., Васюк Ю.А., Галявич А.С., Гарганеева А.А., Гендлин Г.Е., Гиляревский С.Р., Глезер М.Г., Драпкина О.М., Дупляков Д.В., Кобалава Ж.Д., Козиолова Н.А., Лопатин Ю.М., Мареев Ю.В., Моисеев В.С., Недошивин А.О., Перепеч Н.Б., Ситникова М.Ю., Скибицкий В.В., Тарловская Е.И., Чесникова А.И., Шляхто Е.В. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН). Сердечная Недостаточность. 2017;18(1):3-40 https://doi.org/10.18087 /rhfj.2017.1.2346
- Harnett J.D, Foley R.N, Kent G.M, Barre E, Murray D, Parfrey P. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis, and risk factors. Kidney Int. 1995;47:884-90. https://doi.org/ 10.1038/ki.1995.132
- Bhatia R.S, Tu J.V, Lee D.S, Austin P.C, Fang J, Haouzi A, Gong Y, Liu P.P. Outcome of heart failure with preserved ejection fraction in a population - based study. N Engl J Med. 2006;355:260-69. https://doi.org/10.1056/ NEJMoa051530
- Herget-Rosenthal S, Bökenkam A, Hofmann W. How to estimate GFR-serum creatinine, serum cystatin C or equations? Clin Biochem. 2007;40(3-4):153-61. https://doi.org/10.1016/j.clinbiochem.2006. 10.014
- Каюков И.Г., Смирнов А.В., Эмануэль В.Л. Цистатин С в современной медицине. Нефрология. 2012;16(1):22-39
- Moran A, Katz R, Smith N.L, Fried L, Sarnak M, Seliger S, Psaty B, Siscovick D, Gottdiener J, Shlipak M. Cystatin C concentration as a predictor of systolic and diastolic heart failure. J Card Fail. 2008;14:19-26. https://doi.org/10.1016/j.cardfail.2007.09.002
- Ix J.H, Shlipak M.G, Chertow G.M, Ali S, Schiller N, Whooley M. Cystatin C, Left Ventricular Hypertrophy, and Diastolic Dysfunction: Data From the Heart and Soul Study. J Card Fail. 2006; 12(8):601-07. https://doi.org/10.1016/j.cardfail.2006.07.005
- Швецов М.Ю. Хроническая болезнь почек как общемедицинская проблема: современные принципы нефропрофилактики и нефропротекции. Consilium Medicum. 2014;17(7):51-64
- Stevens P, Levin A. Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline. Ann Intern Med. 2013;158(11):825-31. https://doi.org/1010.7326/0003-4819-158-11-201306040-00007
- Sidmal P.S, Mallikarjun H.P, Shekarappa K.C. Pattern and severity of left ventricular diastolic dysfunction in early and end stage renal disease patients with or without dialysis in rural population in South India. International J Biomed Res. 2015;6(08):546-53. https://doi.org/ 10.7439/ijbr
- Farshid A, Pathak R, Shadbolt B, Arnolda L, Talaulikar G. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrology. 2013;14:280. http://dx.doi.org/10. 1186/1471-2369-14-280
- Шутов А.М., Куликова Е.С., Ивашкина Т.Н., Кондратьева Н.И. Анемия и диастолическая функция левого желудочка у больных с додиализной хронической почечной недостаточностью. Нефрология и диализ. 2001;3(4):422-26
- Park M, Hsu C-y, Li Y, Mishra R.K, Keane M, Rosas S.E, Dries D, Xie D, Chen J, He J, Anderson A, Go A, Shlipak M.G. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012;23:1725-34. http://dx.doi.org/10.1681/ ASN. 2012020145
- Elloual F, Berkch F, Bayahia R, Benamar L, Cherti M. Comparison of the Effects of Dialysis Methods (Haemodialysis vs Peritoneal Dialysis) on Diastolic Left Ventricular Function Dialysis Methods and Diastolic Function. Open Cardiovasc Med J. 2016;10:171-78. http://dx.doi.org/ 10.2174/1874192401610010171
- Hayashi S.Y, Rohani M, Lindholm B, Brodin L-A, Lind B, Barany P, Alvestrand F, Seeberger A. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging. Nephrol Dial Transplant. 2006;21:125-32. http://dx.doi.org 10.1093/ndt/gfi075
- Losi M.A, Memoli B, Contaldi C, Barbati G, del Prete M, Betocchi S, Cavallaro M, Carpinella G, Fundaliotis A, Parrella L.S, Parisi L, Guida B, Chiariello M. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant. 2010;25(6):1950-4. http://dx.doi.org10.1093/ndt/gfp747
- Sarnak M.J, Coronado B.E, Greene T, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 2002;57:327-35.
- Кутырина И.М., Руденко Т.Е., Швецов М.Ю., Кушнир В.В. Факторы риска сердечно - сосудистых осложнений у больных на додиализной стадии хронической почечной недостаточности. Терапевтический архив. 2006;5:45-50
- Dervisoglu E, Kozdag G, Etiler N, Kalender B. Association of glomerular filtration rate and inflammation with left ventricular hypertrophy in chronic kidney disease patients. Hippokratia. 2012;16(2):137-42. PMID: 23935269. PMCID: PMC3738415
- Steptoe A, Kivimäki M, Lowe G, Rumley A, Hamer M. Blood Pressure and Fibrinogen Responses to Mental Stress as Predictors of Incident Hypertension over an 8-Year Period. Ann Behav Med. 2016;50:898-906. https://doi.org/10.1007/s12160-016-9817-5
- Catena C, Colussi G, Fedrizzi S, Sechi L.A. Association of a prothrombotic state with left - ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study. J Hypertens. 2013;31(10):2077-84. https://doi.org/10.1097/HJH.0b013e328362d951
- Fassett R, Venuthurupalli S.K, Gobe G.G, Coombes J.S, Cooper M.A, Hoy W.E. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011;80(8):806-21. http://dx.doi.org/10.1038/ki.2011.198
- Weiner D.E, Tighiouart H, Elsayed E.F, Griffith J.L, Salem D.N, Levey A.S, Sarnak M.J. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis. 2008;51(2):212-23. http://dx.doi.org/ 10.1053/j.ajkd.2007.10.035
- Agarwal S, Thohan V, Shlipak M.G, Lima J, Bluemke D, Siscovick D, Gomes A, Herrington D. Association between Cystatin C and MRI Measures of Left Ventricular Structure and Function: Multi-Ethnic Study of Atherosclerosis. Intern J Nephrology. 2011:1-7. https://doi.org/ 10.4061/2011/153868
- Patel P, Ayers C.R, Murphy S, Peshock R, Khera A, de Lemos J.A, Balko J.A, Gupta S, Mammen P.P.A, Drazner M.H, Markham D.W.Association of Cystatin C With Left Ventricular Structure and Function: The Dallas Heart Study. Circulation: Heart Fail. 2009;2:98-104. https://doi.org/10.1161/circheartfailure.108.807271
- Sakuragi S, Ichikawa K, Yamada K, Tanimoto M, Miki T, Otsuka H, Yamamoto K, Kawamoto K, Katayama Y, Tanakaya M, Ito H. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease. Int J Cardiol. 2015;190:287-92. https://doi.org/10.1016/j.ijcard.2015.04.189
- Brady T.M, Townsend K, Schneider M.F, Cox C, Kimball T, Madueme P, Warady B, Furth S, Mitsnefes M. Cystatin C and Cardiac Measures in Children and Adolescents With CKD. Am J Kidney Dis. 2017;6(2):247-56. https://doi.org/10.1053/j.ajkd.2016.08.036
- Djoussé L, Kurth T, Gaziano M.J. Cystatin C and Risk of Heart Failure in the Physicians’ Health Study. Am Heart J. 2008;155(1):82-6. https://doi.org/ 10.1016/j.ahj.2007.08.023
- Taglieri1 N, Koenig W, Kaski J.C. Cystatin C and Cardiovascular Risk. Clinical Chemistry. 2009;55(11):1932-43. https://doi.org/10.1373/ clinchem.2009.128397
- Shlipak M.G, Katz R, Cushman M, Sarnak M.J, Stehman-Breen C, Psaty B.M, Siscovick D, Tracy R.P, Newman A, Fried L. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005;118:1416.e25-1416.e31. https://doi.org/10.1016/j.amjmed.2005. 07.060
- Singh D, Whooley M.A, Ix J.H, Ali S, Shlipak M.G. Association of cystatin C and estimated GFR with inflammatory biomarkers: Heart and Soul Study. Nephrol Dial Transplant. 2007;22:1087-92. https://doi.org/ 10.1093/ndt/gfl744.
- Xie L, Terrand J, Xu B, Tsaprailis G, Boyer J, Chen Q.M. Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation. Cardiovasc Res. 2010;87:628-35. https://doi.org/ 10.1093/cvr/ cvq138
- Козловская Л.В., Бобкова И.Н., Варшавский В.А., Проскурнева Е.П., Мирошниченко Н.Г., Чеботарева Н.В., Мухин Н.А. Фибронектин мочи как показатель процессов фиброзирования в почке при нефрите. Терапевтический архив. 1997;6:34-8